Skila’s Susan Dorfman to Chair CBI’s Premier Bio/Pharmaceutical Forum on Integrated Opinion Leader Management Systems
Morris Plains, NJ, November 14, 2008 – On November 17 and 18, 2008, Skila’s Susan Dorfman, VP Global Marketing, will Chair CBI’s Premier Bio/Pharmaceutical Forum on Integrated Opinion Leader Management Systems being held in King of Prussia, PA.
The forum will focus on the development of effective systems that capture thought leader engagement information, ensure appropriate analysis, increase transparency and improve compliance across global functional departments.
“Establishing lasting and collaborative Relationships with key customer is critical impoertance for Pharmaceutical, Diagnostic, Biotech and Medical Device companies. As a result, a holistic approach to managing relationships with these physician and opinion leader has become a key. Exploring the opportunities and challenges associated with the technologies that can empower more impactful and meaningful interactions makes this forum very apropos,” says Susan Dorfman, VP Global Marketing and Alliance Management, Skila. “The experts who will be presenting will touch on many critical areas relevant to the topic as they share their experiences and best practices."
This is a debut program for CBI and immediately precedes CBI’s 5th Annual Forum on Defining Appropriate and Effective Interactions with Thought Leaders. This event will take place November 17 and 18, 2008 at The Dolce Hotels and Resorts Valley Forge in King of Prussia, PA.
About Skila
Skila, a BelHealth investment company, is a global technology and services company specializing in fully managed "Solution" as-a-Service (SaaS) product launch lifecycle management and engagement / relationship management solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, market access, executive and alliance management teams that include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.
Having developed strong relationships with a broad number of global pharmaceutical companies, Skila’s solutions have been deployed in 61 countries, supporting numerous global brands and more than 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the exponential growth and adoption of our methodology, technology and continuous services as the business platform of choice for our clients.
BelHealth is a private healthcare investment fund. For more info, visit www.belhealth.com.
